ArticleClinical drug investigation2019

Dabrafenib Plus Trametinib for BRAF V600E-Mutant Non-small Cell Lung Cancer: A Patient Case Report.

Janet PanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.